EP3535298
Mótefni gegn PD-1 og notkun þeirra
Status:
EP Einkaleyfi fallið úr gildiEP appl. date:
1.11.2017EP published:
8.9.2021EP application number:
17808224.4
EP translation filed:
12.11.2021Grant published:
15.12.2021EPO information:
European Patent Register
Max expiry date:
31.10.2037Expiry date:
31.10.2024
Title:
ANTIBODIES TO PD-1 AND USES THEREOF
Timeline
Today
1.11.2017EP application
8.9.2021EP Publication
12.11.2021Translation submitted
15.12.2021Registration published
31.10.2024Expires
Owner
Name:
Jounce Therapeutics, Inc.Address:
780 Memorial Drive, Cambridge, MA 02139, US
Inventor
Name:
MABRY, George Robert, IIIAddress:
Cambridge, Massachusetts 02139, US
Name:
SAZINSKY, StephenAddress:
Cambridge, Massachusetts 02139, US
Agent
Name:
Árnason Faktor ehf.Address:
Guðríðarstíg 2-4, 113, Reykjavík,
Priority
Number:
201662416602 PDate:
2.11.2016Country:
US
Classification
Categories:
C07K 16/28, A61P 35/00
Annual fees
Number
Paid
Expires
Payer
Number: 5
Paid: 11.11.2021
Expires: 31.10.2022
Payer: G.H. Sigurgeirsson ehf.
Number: 6
Paid: 11.11.2022
Expires: 31.10.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 6
Paid: 11.11.2022
Expires: 31.10.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 6
Paid: 11.11.2022
Expires: 31.10.2023
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 10.11.2023
Expires: 31.10.2024
Payer: G.H. Sigurgeirsson ehf.
Number: 7
Paid: 10.11.2023
Expires: 31.10.2024
Payer: G.H. Sigurgeirsson ehf.